By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arno Therapeutics 

30 Two Bridges Road
Suite 270
Fairfield  New Jersey  07004  U.S.A.
Phone: 862-703-7170 Fax: 973-227-5759


Company News
Arno Therapeutics Reports First Quarter 2015 Financial And Business Update 5/17/2015 4:47:22 PM
Arno Therapeutics Announces Preclinical Data Demonstrating Broad-Spectrum Antiviral Activity For AR-12 5/15/2015 7:13:37 AM
Arno Therapeutics Announces Data Validating Continued Onapristone And Companion Diagnostic Development At ASCO Annual Meeting 2015 5/14/2015 1:20:40 PM
Arno Therapeutics Receives USPTO Notice Of Allowance For Two Important Patents Covering Lead Compound Onapristone 5/7/2015 7:42:07 AM
Arno Therapeutics Receives European Orphan Drug Designation For AR-12 To Treat Two Infectious Diseases 4/30/2015 7:41:26 AM
Arno Therapeutics To Present Promising Data From Phase I Trial Of Onapristone At AACR Annual Meeting 2015 4/21/2015 7:46:24 AM
Arno Therapeutics Announces Three Poster Presentations At Upcoming American Association for Cancer Research Annual Meeting 2015 4/13/2015 8:03:09 AM
Arno Therapeutics Reports Fourth Quarter 2014 Financial And Business Update 4/1/2015 11:56:05 AM
New Data Supporting Arno Therapeutics' HDAC Inhibitor AR-42 Published In The Journal of Urology 3/24/2015 7:27:49 AM
Arno Therapeutics To Present At 11th Annual Noble Equity Conference 1/8/2015 1:21:15 PM